+91-22-489139092019 ലെ മികച്ച 10 പെർഫോർമിംഗ് സെക്ടർ ഫണ്ടുകൾ
മേഖലമ്യൂച്വൽ ഫണ്ടുകൾ ഒരു പ്രത്യേക മേഖലയിലെ കമ്പനികളുടെ ഇക്വിറ്റി ഷെയറുകളിൽ അവരുടെ ഫണ്ട് പണത്തിന്റെ പ്രധാന പങ്ക് നിക്ഷേപിക്കുന്ന സ്കീമിനെ കാണുക. ഈ സ്കീമുകൾ അന്വേഷിക്കുന്ന വ്യക്തികൾ അന്വേഷിക്കുന്നുഉയർന്ന വരുമാനം അവരുടെ നിക്ഷേപത്തിൽ aഉയർന്ന അപകടസാധ്യത വിശപ്പ്. മ്യൂച്വൽ ഫണ്ടുകൾ സാധാരണയായി അവരുടെ സ്കീമുകൾ വാഗ്ദാനം ചെയ്യുന്ന ചില മേഖലകളിൽ അടിസ്ഥാന സ, കര്യങ്ങൾ, ഫാർമസ്യൂട്ടിക്കൽ, ബാങ്കിംഗ്, ധനകാര്യ സേവനങ്ങൾ, പ്രകൃതിവിഭവങ്ങൾ, പുതിയ .ർജ്ജം എന്നിവ ഉൾപ്പെടുന്നു. 2019 ലെ മേഖലാ ഫണ്ടുകളുടെ പ്രകടനം ഗണ്യമായി മികച്ചതാണ്. സമ്പദ്‌വ്യവസ്ഥയിലെ സംഭവവികാസങ്ങളോടെ, പല മേഖലാ ഫണ്ടുകളും അവരുടെ നിക്ഷേപങ്ങളിൽ നല്ല വരുമാനം നേടി. അതിനാൽ, 2019 ലെ മികച്ചതും മികച്ചതുമായ 10 പെർഫോമൻസ് സെക്ടർ മ്യൂച്വൽ ഫണ്ടുകളിൽ ചിലത് അവരുടെ പ്രകടനത്തിന്റെ അടിസ്ഥാനത്തിൽ (വരുമാനം) നോക്കാം.
Talk to our investment specialist
പ്രകടനത്തെ അടിസ്ഥാനമാക്കി 2019 ലെ മികച്ച 10 പെർഫോർമിംഗ് സെക്ടർ മ്യൂച്വൽ ഫണ്ടുകൾ
Fund NAV Net Assets (Cr) 2024 (%) 2023 (%) 2022 (%) 2021 (%) 2020 (%) LIC MF Infrastructure Fund Growth ₹49.0537
↓ -0.01 ₹995 47.8 44.4 7.9 46.6 -0.1 UTI Healthcare Fund Growth ₹284.315
↓ -0.06 ₹1,119 42.9 38.2 -12.3 19.1 67.4 SBI Healthcare Opportunities Fund Growth ₹419.374
↓ -0.27 ₹3,963 42.2 38.2 -6 20.1 65.8 TATA India Pharma & Healthcare Fund Growth ₹29.997
↑ 0.01 ₹1,309 40.4 36.6 -8 19.1 64.4 Bandhan Infrastructure Fund Growth ₹49.072
↑ 0.03 ₹1,613 39.3 50.3 1.7 64.8 6.3 Franklin India Opportunities Fund Growth ₹253.35
↓ -0.49 ₹7,509 37.3 53.6 -1.9 29.7 27.3 Canara Robeco Infrastructure Growth ₹160.25
↓ -0.36 ₹889 35.3 41.2 9 56.1 9 Nippon India Pharma Fund Growth ₹495.989
↓ -1.74 ₹8,357 34 39.2 -9.9 23.9 66.4 Invesco India Infrastructure Fund Growth ₹62.34
↑ 0.06 ₹1,524 33.2 51.1 2.3 55.4 16.2 Kotak Infrastructure & Economic Reform Fund Growth ₹64.012
↓ -0.14 ₹2,313 32.4 37.3 15.6 57.3 3.4 Note: Returns up to 1 year are on absolute basis & more than 1 year are on CAGR basis. as on 30 Sep 25 Research Highlights & Commentary of 10 Funds showcased
Commentary LIC MF Infrastructure Fund UTI Healthcare Fund SBI Healthcare Opportunities Fund TATA India Pharma & Healthcare Fund Bandhan Infrastructure Fund Franklin India Opportunities Fund Canara Robeco Infrastructure Nippon India Pharma Fund Invesco India Infrastructure Fund Kotak Infrastructure & Economic Reform Fund Point 1 Bottom quartile AUM (₹995 Cr). Bottom quartile AUM (₹1,119 Cr). Upper mid AUM (₹3,963 Cr). Lower mid AUM (₹1,309 Cr). Upper mid AUM (₹1,613 Cr). Top quartile AUM (₹7,509 Cr). Bottom quartile AUM (₹889 Cr). Highest AUM (₹8,357 Cr). Lower mid AUM (₹1,524 Cr). Upper mid AUM (₹2,313 Cr). Point 2 Established history (17+ yrs). Oldest track record among peers (26 yrs). Established history (20+ yrs). Established history (9+ yrs). Established history (14+ yrs). Established history (25+ yrs). Established history (19+ yrs). Established history (21+ yrs). Established history (17+ yrs). Established history (17+ yrs). Point 3 Not Rated. Rating: 1★ (lower mid). Rating: 2★ (upper mid). Not Rated. Top rated. Rating: 3★ (upper mid). Not Rated. Rating: 2★ (lower mid). Rating: 3★ (upper mid). Rating: 4★ (top quartile). Point 4 Risk profile: High. Risk profile: High. Risk profile: High. Risk profile: High. Risk profile: High. Risk profile: Moderately High. Risk profile: High. Risk profile: High. Risk profile: High. Risk profile: High. Point 5 5Y return: 31.75% (upper mid). 5Y return: 16.97% (bottom quartile). 5Y return: 18.88% (lower mid). 5Y return: 17.13% (bottom quartile). 5Y return: 33.09% (top quartile). 5Y return: 28.48% (lower mid). 5Y return: 31.80% (top quartile). 5Y return: 17.08% (bottom quartile). 5Y return: 29.80% (upper mid). 5Y return: 30.07% (upper mid). Point 6 3Y return: 27.51% (top quartile). 3Y return: 23.73% (lower mid). 3Y return: 24.67% (lower mid). 3Y return: 21.67% (bottom quartile). 3Y return: 26.59% (upper mid). 3Y return: 29.76% (top quartile). 3Y return: 25.50% (upper mid). 3Y return: 20.69% (bottom quartile). 3Y return: 25.14% (upper mid). 3Y return: 21.30% (bottom quartile). Point 7 1Y return: -5.72% (lower mid). 1Y return: -1.89% (top quartile). 1Y return: -0.18% (top quartile). 1Y return: -3.74% (upper mid). 1Y return: -12.66% (bottom quartile). 1Y return: -2.26% (upper mid). 1Y return: -5.19% (lower mid). 1Y return: -5.14% (upper mid). 1Y return: -9.05% (bottom quartile). 1Y return: -11.40% (bottom quartile). Point 8 Alpha: -1.71 (bottom quartile). Alpha: 0.79 (upper mid). Alpha: 2.04 (upper mid). Alpha: 3.78 (top quartile). Alpha: 0.00 (upper mid). Alpha: 2.40 (top quartile). Alpha: 0.00 (lower mid). Alpha: -4.31 (bottom quartile). Alpha: 0.00 (lower mid). Alpha: -1.88 (bottom quartile). Point 9 Sharpe: -0.46 (lower mid). Sharpe: -0.15 (top quartile). Sharpe: -0.05 (top quartile). Sharpe: -0.39 (upper mid). Sharpe: -0.71 (bottom quartile). Sharpe: -0.43 (lower mid). Sharpe: -0.41 (upper mid). Sharpe: -0.47 (bottom quartile). Sharpe: -0.40 (upper mid). Sharpe: -0.52 (bottom quartile). Point 10 Information ratio: 0.34 (upper mid). Information ratio: 0.10 (upper mid). Information ratio: 0.38 (upper mid). Information ratio: 0.78 (top quartile). Information ratio: 0.00 (lower mid). Information ratio: 1.75 (top quartile). Information ratio: 0.00 (lower mid). Information ratio: -0.53 (bottom quartile). Information ratio: 0.00 (bottom quartile). Information ratio: -0.04 (bottom quartile). LIC MF Infrastructure Fund
UTI Healthcare Fund
SBI Healthcare Opportunities Fund
TATA India Pharma & Healthcare Fund
Bandhan Infrastructure Fund
Franklin India Opportunities Fund
Canara Robeco Infrastructure
Nippon India Pharma Fund
Invesco India Infrastructure Fund
Kotak Infrastructure & Economic Reform Fund
2019 ലെ മികച്ച പ്രകടന മേഖല ഫണ്ടുകൾ
The investment objective of the scheme is to provide long term growth from a portfolio of equity / equity related instruments of companies engaged either directly or indirectly in the infrastructure sector. Below is the key information for LIC MF Infrastructure Fund Returns up to 1 year are on (Erstwhile UTI Pharma & Healthcare Fund) The Investment objective of the Scheme is capital appreciation through investments in equities and equity related instruments of the Pharma & Healthcare sectors. Research Highlights for UTI Healthcare Fund Below is the key information for UTI Healthcare Fund Returns up to 1 year are on (Erstwhile SBI Pharma Fund) To provide the investors maximum growth opportunity through equity
investments in stocks of growth oriented sectors of the economy. Research Highlights for SBI Healthcare Opportunities Fund Below is the key information for SBI Healthcare Opportunities Fund Returns up to 1 year are on The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved.The Scheme does not assure or guarantee any returns. Research Highlights for TATA India Pharma & Healthcare Fund Below is the key information for TATA India Pharma & Healthcare Fund Returns up to 1 year are on The investment objective of the scheme is to seek to generate long-term capital growth through an active diversified portfolio of predominantly equity and equity related instruments of companies that are participating in and benefiting from growth in Indian infrastructure and infrastructural related activities. However, there can be no assurance that the investment objective of the scheme will be realized. Research Highlights for Bandhan Infrastructure Fund Below is the key information for Bandhan Infrastructure Fund Returns up to 1 year are on The investment objective of Franklin India Opportunities Fund (FIOF) is to generate capital appreciation by capitalizing on the long-term growth opportunities in the Indian economy. Research Highlights for Franklin India Opportunities Fund Below is the key information for Franklin India Opportunities Fund Returns up to 1 year are on T o g e n e r a t e income/capital appreciation by investing in equities and equity related instruments of companies in the infrastructure sector. However, there can be no assurance that the investment objective of the scheme will be realized. Research Highlights for Canara Robeco Infrastructure Below is the key information for Canara Robeco Infrastructure Returns up to 1 year are on The primary investment objective of the scheme is to seek to generate consistent returns by investing in equity and equity related or fixed income securities of Pharma and other associated companies. Research Highlights for Nippon India Pharma Fund Below is the key information for Nippon India Pharma Fund Returns up to 1 year are on The Scheme seeks to provide long term capital appreciation by investing in a portfolio that is predominantly constituted of equity and equity related instruments of infrastructure companies. However, there can be no assurance that the investment objective of the Scheme will be achieved. Research Highlights for Invesco India Infrastructure Fund Below is the key information for Invesco India Infrastructure Fund Returns up to 1 year are on The investment objective of the Scheme is to generate long-term capital appreciation from a diversified portfolio of predominantly (at least 65%) equity and equity-related securities of companies involved in economic development of India as a result of potential investments in infrastructure and unfolding economic reforms. Research Highlights for Kotak Infrastructure & Economic Reform Fund Below is the key information for Kotak Infrastructure & Economic Reform Fund Returns up to 1 year are on 1. LIC MF Infrastructure Fund
LIC MF Infrastructure Fund
Growth Launch Date 29 Feb 08 NAV (30 Sep 25) ₹49.0537 ↓ -0.01 (-0.03 %) Net Assets (Cr) ₹995 on 31 Aug 25 Category Equity - Sectoral AMC LIC Mutual Fund Asset Mgmt Co Ltd Rating Risk High Expense Ratio 2.21 Sharpe Ratio -0.47 Information Ratio 0.34 Alpha Ratio -1.71 Min Investment 5,000 Min SIP Investment 1,000 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 30 Sep 20 ₹10,000 30 Sep 21 ₹17,349 30 Sep 22 ₹19,152 30 Sep 23 ₹24,311 30 Sep 24 ₹42,112 Returns for LIC MF Infrastructure Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 30 Sep 25 Duration Returns 1 Month 3.4% 3 Month -3.4% 6 Month 12.4% 1 Year -5.7% 3 Year 27.5% 5 Year 31.8% 10 Year 15 Year Since launch 9.5% Historical performance (Yearly) on absolute basis
Year Returns 2024 47.8% 2023 44.4% 2022 7.9% 2021 46.6% 2020 -0.1% 2019 13.3% 2018 -14.6% 2017 42.2% 2016 -2.2% 2015 -6.2% Fund Manager information for LIC MF Infrastructure Fund
Name Since Tenure Yogesh Patil 18 Sep 20 4.96 Yr. Mahesh Bendre 1 Jul 24 1.17 Yr. Data below for LIC MF Infrastructure Fund as on 31 Aug 25
Equity Sector Allocation
Sector Value Industrials 50.96% Basic Materials 9.62% Financial Services 7.78% Consumer Cyclical 6.93% Utility 5.82% Technology 4.2% Health Care 4.07% Real Estate 3.47% Communication Services 2.94% Energy 0.9% Asset Allocation
Asset Class Value Cash 3.31% Equity 96.69% Top Securities Holdings / Portfolio
Name Holding Value Quantity Shakti Pumps (India) Ltd (Industrials)
Equity, Since 31 Mar 24 | SHAKTIPUMP6% ₹56 Cr 693,857 Larsen & Toubro Ltd (Industrials)
Equity, Since 30 Apr 09 | LT4% ₹39 Cr 109,584 Apollo Hospitals Enterprise Ltd (Healthcare)
Equity, Since 30 Jun 25 | APOLLOHOSP4% ₹36 Cr 46,843 Afcons Infrastructure Ltd (Industrials)
Equity, Since 31 Oct 24 | AFCONS3% ₹32 Cr 769,765 REC Ltd (Financial Services)
Equity, Since 31 Jul 23 | RECLTD3% ₹32 Cr 911,009 Schneider Electric Infrastructure Ltd (Industrials)
Equity, Since 31 Dec 23 | SCHNEIDER3% ₹27 Cr 319,302 Avalon Technologies Ltd (Technology)
Equity, Since 31 Jul 23 | AVALON3% ₹26 Cr 310,615 Cummins India Ltd (Industrials)
Equity, Since 31 May 21 | CUMMINSIND3% ₹26 Cr 67,407 Garware Hi-Tech Films Ltd (Basic Materials)
Equity, Since 31 Aug 23 | 5006553% ₹25 Cr 94,287 Mahindra Lifespace Developers Ltd (Real Estate)
Equity, Since 30 Jun 24 | MAHLIFE2% ₹23 Cr 666,245 2. UTI Healthcare Fund
UTI Healthcare Fund
Growth Launch Date 28 Jun 99 NAV (30 Sep 25) ₹284.315 ↓ -0.06 (-0.02 %) Net Assets (Cr) ₹1,119 on 31 Aug 25 Category Equity - Sectoral AMC UTI Asset Management Company Ltd Rating ☆ Risk High Expense Ratio 2.26 Sharpe Ratio -0.15 Information Ratio 0.1 Alpha Ratio 0.79 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 30 Sep 20 ₹10,000 30 Sep 21 ₹13,129 30 Sep 22 ₹11,561 30 Sep 23 ₹14,305 30 Sep 24 ₹22,319 Returns for UTI Healthcare Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 30 Sep 25 Duration Returns 1 Month -1.5% 3 Month -0.6% 6 Month 6% 1 Year -1.9% 3 Year 23.7% 5 Year 17% 10 Year 15 Year Since launch 14.8% Historical performance (Yearly) on absolute basis
Year Returns 2024 42.9% 2023 38.2% 2022 -12.3% 2021 19.1% 2020 67.4% 2019 1.2% 2018 -7.5% 2017 6.2% 2016 -9.7% 2015 12.4% Fund Manager information for UTI Healthcare Fund
Name Since Tenure Kamal Gada 2 May 22 3.34 Yr. Data below for UTI Healthcare Fund as on 31 Aug 25
Equity Sector Allocation
Sector Value Health Care 98.23% Basic Materials 1.12% Asset Allocation
Asset Class Value Cash 0.65% Equity 99.35% Top Securities Holdings / Portfolio
Name Holding Value Quantity Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Oct 06 | SUNPHARMA9% ₹105 Cr 661,016 Cipla Ltd (Healthcare)
Equity, Since 31 Jan 03 | CIPLA6% ₹64 Cr 400,000 Ajanta Pharma Ltd (Healthcare)
Equity, Since 31 Jul 17 | AJANTPHARM5% ₹60 Cr 242,673
↑ 42,673 Lupin Ltd (Healthcare)
Equity, Since 28 Feb 25 | LUPIN5% ₹51 Cr 270,000
↑ 15,000 Dr Reddy's Laboratories Ltd (Healthcare)
Equity, Since 28 Feb 18 | DRREDDY4% ₹45 Cr 360,000 Procter & Gamble Health Ltd (Healthcare)
Equity, Since 31 Dec 20 | PGHL4% ₹45 Cr 70,039
↓ -10,244 Fortis Healthcare Ltd (Healthcare)
Equity, Since 31 Dec 20 | FORTIS4% ₹42 Cr 465,000 Glenmark Pharmaceuticals Ltd (Healthcare)
Equity, Since 31 Mar 24 | GLENMARK4% ₹42 Cr 220,000
↑ 30,000 Apollo Hospitals Enterprise Ltd (Healthcare)
Equity, Since 30 Apr 21 | APOLLOHOSP4% ₹40 Cr 53,000 Alkem Laboratories Ltd (Healthcare)
Equity, Since 31 May 21 | ALKEM3% ₹38 Cr 72,000
↑ 17,000 3. SBI Healthcare Opportunities Fund
SBI Healthcare Opportunities Fund
Growth Launch Date 31 Dec 04 NAV (29 Sep 25) ₹419.374 ↓ -0.27 (-0.07 %) Net Assets (Cr) ₹3,963 on 31 Aug 25 Category Equity - Sectoral AMC SBI Funds Management Private Limited Rating ☆☆ Risk High Expense Ratio 1.97 Sharpe Ratio -0.05 Information Ratio 0.38 Alpha Ratio 2.04 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-15 Days (0.5%),15 Days and above(NIL) Growth of 10,000 investment over the years.
Date Value 30 Sep 20 ₹10,000 30 Sep 21 ₹13,138 30 Sep 22 ₹12,251 30 Sep 23 ₹15,800 30 Sep 24 ₹23,614 Returns for SBI Healthcare Opportunities Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 30 Sep 25 Duration Returns 1 Month -1.9% 3 Month -2% 6 Month 1.9% 1 Year -0.2% 3 Year 24.7% 5 Year 18.9% 10 Year 15 Year Since launch 15.2% Historical performance (Yearly) on absolute basis
Year Returns 2024 42.2% 2023 38.2% 2022 -6% 2021 20.1% 2020 65.8% 2019 -0.5% 2018 -9.9% 2017 2.1% 2016 -14% 2015 27.1% Fund Manager information for SBI Healthcare Opportunities Fund
Name Since Tenure Tanmaya Desai 1 Jun 11 14.26 Yr. Data below for SBI Healthcare Opportunities Fund as on 31 Aug 25
Equity Sector Allocation
Sector Value Health Care 90.36% Basic Materials 5.79% Asset Allocation
Asset Class Value Cash 3.85% Equity 96.15% Top Securities Holdings / Portfolio
Name Holding Value Quantity Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Dec 17 | SUNPHARMA11% ₹431 Cr 2,700,000 Divi's Laboratories Ltd (Healthcare)
Equity, Since 31 Mar 12 | DIVISLAB7% ₹270 Cr 440,000 Max Healthcare Institute Ltd Ordinary Shares (Healthcare)
Equity, Since 31 Mar 21 | 5432206% ₹242 Cr 2,100,000 Cipla Ltd (Healthcare)
Equity, Since 31 Aug 16 | CIPLA5% ₹191 Cr 1,200,000 Lonza Group Ltd ADR (Healthcare)
Equity, Since 31 Jan 24 | LO3A4% ₹168 Cr 270,000 Lupin Ltd (Healthcare)
Equity, Since 31 Aug 23 | LUPIN4% ₹159 Cr 840,000 Torrent Pharmaceuticals Ltd (Healthcare)
Equity, Since 30 Jun 21 | TORNTPHARM4% ₹142 Cr 400,000
↑ 80,000 Mankind Pharma Ltd (Healthcare)
Equity, Since 30 Apr 23 | MANKIND3% ₹138 Cr 560,000 Fortis Healthcare Ltd (Healthcare)
Equity, Since 30 Apr 21 | FORTIS3% ₹137 Cr 1,500,000 Gland Pharma Ltd (Healthcare)
Equity, Since 30 Nov 20 | GLAND3% ₹131 Cr 700,000 4. TATA India Pharma & Healthcare Fund
TATA India Pharma & Healthcare Fund
Growth Launch Date 28 Dec 15 NAV (30 Sep 25) ₹29.997 ↑ 0.01 (0.02 %) Net Assets (Cr) ₹1,309 on 31 Aug 25 Category Equity - Sectoral AMC Tata Asset Management Limited Rating Risk High Expense Ratio 2.17 Sharpe Ratio -0.39 Information Ratio 0.78 Alpha Ratio 3.78 Min Investment 5,000 Min SIP Investment 150 Exit Load 0-3 Months (0.25%),3 Months and above(NIL) Growth of 10,000 investment over the years.
Date Value 30 Sep 20 ₹10,000 30 Sep 21 ₹13,118 30 Sep 22 ₹12,243 30 Sep 23 ₹14,936 30 Sep 24 ₹22,907 Returns for TATA India Pharma & Healthcare Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 30 Sep 25 Duration Returns 1 Month -1.3% 3 Month -0.7% 6 Month 4.7% 1 Year -3.7% 3 Year 21.7% 5 Year 17.1% 10 Year 15 Year Since launch 11.9% Historical performance (Yearly) on absolute basis
Year Returns 2024 40.4% 2023 36.6% 2022 -8% 2021 19.1% 2020 64.4% 2019 5.5% 2018 -2.6% 2017 4.7% 2016 -14.7% 2015 Fund Manager information for TATA India Pharma & Healthcare Fund
Name Since Tenure Rajat Srivastava 16 Sep 24 0.96 Yr. Data below for TATA India Pharma & Healthcare Fund as on 31 Aug 25
Equity Sector Allocation
Sector Value Health Care 94.45% Financial Services 1.56% Basic Materials 1.44% Asset Allocation
Asset Class Value Cash 2.56% Equity 97.44% Top Securities Holdings / Portfolio
Name Holding Value Quantity Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Jan 16 | SUNPHARMA10% ₹130 Cr 815,483
↓ -40,979 Cipla Ltd (Healthcare)
Equity, Since 30 Apr 20 | CIPLA7% ₹91 Cr 569,903 Apollo Hospitals Enterprise Ltd (Healthcare)
Equity, Since 31 Dec 16 | APOLLOHOSP5% ₹67 Cr 88,528
↓ -4,298 HealthCare Global Enterprises Ltd (Healthcare)
Equity, Since 31 Dec 18 | HCG5% ₹63 Cr 942,453 Lupin Ltd (Healthcare)
Equity, Since 30 Nov 17 | LUPIN5% ₹63 Cr 330,887 Torrent Pharmaceuticals Ltd (Healthcare)
Equity, Since 31 Aug 22 | TORNTPHARM5% ₹60 Cr 168,394
↑ 13,677 Aster DM Healthcare Ltd Ordinary Shares (Healthcare)
Equity, Since 31 Dec 22 | ASTERDM4% ₹58 Cr 956,991 Alkem Laboratories Ltd (Healthcare)
Equity, Since 31 Aug 20 | ALKEM4% ₹56 Cr 106,435 Max Healthcare Institute Ltd Ordinary Shares (Healthcare)
Equity, Since 31 Jul 25 | 5432204% ₹53 Cr 458,724
↑ 50,807 Divi's Laboratories Ltd (Healthcare)
Equity, Since 30 Sep 17 | DIVISLAB4% ₹51 Cr 83,315
↑ 21,175 5. Bandhan Infrastructure Fund
Bandhan Infrastructure Fund
Growth Launch Date 8 Mar 11 NAV (30 Sep 25) ₹49.072 ↑ 0.03 (0.07 %) Net Assets (Cr) ₹1,613 on 31 Aug 25 Category Equity - Sectoral AMC IDFC Asset Management Company Limited Rating ☆☆☆☆☆ Risk High Expense Ratio 2.1 Sharpe Ratio -0.71 Information Ratio 0 Alpha Ratio 0 Min Investment 5,000 Min SIP Investment 100 Exit Load 0-365 Days (1%),365 Days and above(NIL) Growth of 10,000 investment over the years.
Date Value 30 Sep 20 ₹10,000 30 Sep 21 ₹20,085 30 Sep 22 ₹20,588 30 Sep 23 ₹27,745 30 Sep 24 ₹47,816 Returns for Bandhan Infrastructure Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 30 Sep 25 Duration Returns 1 Month 1.1% 3 Month -5.9% 6 Month 6.8% 1 Year -12.7% 3 Year 26.6% 5 Year 33.1% 10 Year 15 Year Since launch 11.5% Historical performance (Yearly) on absolute basis
Year Returns 2024 39.3% 2023 50.3% 2022 1.7% 2021 64.8% 2020 6.3% 2019 -5.3% 2018 -25.9% 2017 58.7% 2016 10.7% 2015 -0.2% Fund Manager information for Bandhan Infrastructure Fund
Name Since Tenure Vishal Biraia 24 Jan 24 1.6 Yr. Ritika Behera 7 Oct 23 1.9 Yr. Gaurav Satra 7 Jun 24 1.24 Yr. Data below for Bandhan Infrastructure Fund as on 31 Aug 25
Equity Sector Allocation
Sector Value Industrials 53.39% Utility 12.18% Basic Materials 7.23% Communication Services 4.6% Energy 3.81% Financial Services 3.12% Health Care 2.24% Technology 2.22% Consumer Cyclical 1.38% Real Estate 1.2% Asset Allocation
Asset Class Value Cash 8.64% Equity 91.36% Top Securities Holdings / Portfolio
Name Holding Value Quantity Kirloskar Brothers Ltd (Industrials)
Equity, Since 31 Dec 17 | KIRLOSBROS5% ₹84 Cr 433,186
↓ -10,199 Larsen & Toubro Ltd (Industrials)
Equity, Since 29 Feb 12 | LT5% ₹74 Cr 206,262 UltraTech Cement Ltd (Basic Materials)
Equity, Since 31 Mar 14 | ULTRACEMCO4% ₹63 Cr 49,772 Bharti Airtel Ltd (Communication Services)
Equity, Since 30 Apr 19 | BHARTIARTL4% ₹62 Cr 330,018 Reliance Industries Ltd (Energy)
Equity, Since 30 Jun 24 | RELIANCE4% ₹61 Cr 452,706 Bharat Electronics Ltd (Industrials)
Equity, Since 31 Oct 19 | BEL3% ₹53 Cr 1,431,700 GPT Infraprojects Ltd (Industrials)
Equity, Since 30 Nov 17 | GPTINFRA3% ₹53 Cr 4,733,244 Adani Ports & Special Economic Zone Ltd (Industrials)
Equity, Since 31 Dec 23 | ADANIPORTS3% ₹48 Cr 365,137 InterGlobe Aviation Ltd (Industrials)
Equity, Since 31 Aug 24 | INDIGO3% ₹47 Cr 83,887
↑ 34,446 PTC India Financial Services Ltd (Financial Services)
Equity, Since 31 Dec 23 | PFS3% ₹47 Cr 12,400,122 6. Franklin India Opportunities Fund
Franklin India Opportunities Fund
Growth Launch Date 21 Feb 00 NAV (29 Sep 25) ₹253.35 ↓ -0.49 (-0.19 %) Net Assets (Cr) ₹7,509 on 31 Aug 25 Category Equity - Sectoral AMC Franklin Templeton Asst Mgmt(IND)Pvt Ltd Rating ☆☆☆ Risk Moderately High Expense Ratio 1.83 Sharpe Ratio -0.43 Information Ratio 1.75 Alpha Ratio 2.4 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 30 Sep 20 ₹10,000 30 Sep 21 ₹16,667 30 Sep 22 ₹16,312 30 Sep 23 ₹21,669 30 Sep 24 ₹35,745 Returns for Franklin India Opportunities Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 30 Sep 25 Duration Returns 1 Month 0.7% 3 Month 0.2% 6 Month 11.6% 1 Year -2.3% 3 Year 29.8% 5 Year 28.5% 10 Year 15 Year Since launch 13.5% Historical performance (Yearly) on absolute basis
Year Returns 2024 37.3% 2023 53.6% 2022 -1.9% 2021 29.7% 2020 27.3% 2019 5.4% 2018 -10.1% 2017 35.6% 2016 4.2% 2015 2.3% Fund Manager information for Franklin India Opportunities Fund
Name Since Tenure Kiran Sebastian 7 Feb 22 3.57 Yr. R. Janakiraman 1 Apr 13 12.43 Yr. Sandeep Manam 18 Oct 21 3.87 Yr. Data below for Franklin India Opportunities Fund as on 31 Aug 25
Equity Sector Allocation
Sector Value Consumer Cyclical 19.93% Financial Services 19.13% Health Care 13.46% Technology 12.15% Basic Materials 9.15% Communication Services 5.85% Energy 4.47% Industrials 4.4% Utility 2.76% Consumer Defensive 1.9% Real Estate 0.69% Asset Allocation
Asset Class Value Cash 6.09% Equity 93.89% Top Securities Holdings / Portfolio
Name Holding Value Quantity HDFC Bank Ltd (Financial Services)
Equity, Since 31 May 24 | HDFCBANK5% ₹389 Cr 4,087,942 Reliance Industries Ltd (Energy)
Equity, Since 30 Apr 22 | RELIANCE4% ₹336 Cr 2,472,229
↓ -235,050 Axis Bank Ltd (Financial Services)
Equity, Since 30 Apr 25 | AXISBANK4% ₹308 Cr 2,950,277 Eternal Ltd (Consumer Cyclical)
Equity, Since 31 Aug 23 | 5433204% ₹300 Cr 9,548,090 Maruti Suzuki India Ltd (Consumer Cyclical)
Equity, Since 30 Apr 25 | MARUTI3% ₹251 Cr 169,582 Mphasis Ltd (Technology)
Equity, Since 30 Nov 24 | MPHASIS3% ₹227 Cr 814,231 Bharti Airtel Ltd (Communication Services)
Equity, Since 31 Jan 24 | BHARTIARTL3% ₹219 Cr 1,158,502 Sudarshan Chemical Industries Ltd (Basic Materials)
Equity, Since 30 Apr 24 | SUDARSCHEM3% ₹215 Cr 1,435,340 Lemon Tree Hotels Ltd (Consumer Cyclical)
Equity, Since 31 Aug 24 | LEMONTREE3% ₹213 Cr 12,833,401 NTPC Ltd (Utilities)
Equity, Since 31 Aug 22 | NTPC3% ₹207 Cr 6,333,312 7. Canara Robeco Infrastructure
Canara Robeco Infrastructure
Growth Launch Date 2 Dec 05 NAV (30 Sep 25) ₹160.25 ↓ -0.36 (-0.22 %) Net Assets (Cr) ₹889 on 31 Aug 25 Category Equity - Sectoral AMC Canara Robeco Asset Management Co. Ltd. Rating Risk High Expense Ratio 2.32 Sharpe Ratio -0.41 Information Ratio 0 Alpha Ratio 0 Min Investment 5,000 Min SIP Investment 1,000 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 30 Sep 20 ₹10,000 30 Sep 21 ₹17,905 30 Sep 22 ₹20,122 30 Sep 23 ₹25,247 30 Sep 24 ₹41,953 Returns for Canara Robeco Infrastructure
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 30 Sep 25 Duration Returns 1 Month 2.2% 3 Month -1.8% 6 Month 10.9% 1 Year -5.2% 3 Year 25.5% 5 Year 31.8% 10 Year 15 Year Since launch 15% Historical performance (Yearly) on absolute basis
Year Returns 2024 35.3% 2023 41.2% 2022 9% 2021 56.1% 2020 9% 2019 2.3% 2018 -19.1% 2017 40.2% 2016 2.1% 2015 6.7% Fund Manager information for Canara Robeco Infrastructure
Name Since Tenure Vishal Mishra 26 Jun 21 4.19 Yr. Shridatta Bhandwaldar 29 Sep 18 6.93 Yr. Data below for Canara Robeco Infrastructure as on 31 Aug 25
Equity Sector Allocation
Sector Value Industrials 45.04% Utility 12.54% Basic Materials 10.48% Energy 8.11% Financial Services 6.81% Technology 5.5% Consumer Cyclical 3.02% Communication Services 2.9% Real Estate 1.3% Asset Allocation
Asset Class Value Cash 4.3% Equity 95.7% Top Securities Holdings / Portfolio
Name Holding Value Quantity Larsen & Toubro Ltd (Industrials)
Equity, Since 28 Feb 11 | LT8% ₹73 Cr 202,901
↑ 5,000 Reliance Industries Ltd (Energy)
Equity, Since 30 Apr 22 | RELIANCE4% ₹38 Cr 279,250 State Bank of India (Financial Services)
Equity, Since 31 Jul 24 | SBIN4% ₹36 Cr 442,500
↑ 12,500 NTPC Ltd (Utilities)
Equity, Since 30 Nov 18 | NTPC4% ₹35 Cr 1,066,480 InterGlobe Aviation Ltd (Industrials)
Equity, Since 31 Jan 23 | INDIGO4% ₹33 Cr 58,250 GE Vernova T&D India Ltd (Industrials)
Equity, Since 31 Jan 24 | GVT&D4% ₹33 Cr 118,193
↓ -1,640 Bharat Electronics Ltd (Industrials)
Equity, Since 31 Jul 19 | BEL4% ₹32 Cr 869,000 Dixon Technologies (India) Ltd (Technology)
Equity, Since 31 Oct 23 | DIXON4% ₹32 Cr 18,950 Tata Power Co Ltd (Utilities)
Equity, Since 30 Sep 24 | TATAPOWER3% ₹29 Cr 785,000 CG Power & Industrial Solutions Ltd (Industrials)
Equity, Since 31 Oct 23 | CGPOWER3% ₹27 Cr 383,150 8. Nippon India Pharma Fund
Nippon India Pharma Fund
Growth Launch Date 5 Jun 04 NAV (30 Sep 25) ₹495.989 ↓ -1.74 (-0.35 %) Net Assets (Cr) ₹8,357 on 31 Aug 25 Category Equity - Sectoral AMC Nippon Life Asset Management Ltd. Rating ☆☆ Risk High Expense Ratio 1.81 Sharpe Ratio -0.48 Information Ratio -0.53 Alpha Ratio -4.31 Min Investment 5,000 Min SIP Investment 100 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 30 Sep 20 ₹10,000 30 Sep 21 ₹13,642 30 Sep 22 ₹12,514 30 Sep 23 ₹15,630 30 Sep 24 ₹23,190 Returns for Nippon India Pharma Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 30 Sep 25 Duration Returns 1 Month -2.4% 3 Month -4.4% 6 Month 3.1% 1 Year -5.1% 3 Year 20.7% 5 Year 17.1% 10 Year 15 Year Since launch 20.1% Historical performance (Yearly) on absolute basis
Year Returns 2024 34% 2023 39.2% 2022 -9.9% 2021 23.9% 2020 66.4% 2019 1.7% 2018 3.6% 2017 7.6% 2016 -10.6% 2015 19.4% Fund Manager information for Nippon India Pharma Fund
Name Since Tenure Sailesh Raj Bhan 1 Apr 05 20.43 Yr. Kinjal Desai 25 May 18 7.28 Yr. Data below for Nippon India Pharma Fund as on 31 Aug 25
Equity Sector Allocation
Sector Value Health Care 99.48% Asset Allocation
Asset Class Value Cash 0.52% Equity 99.48% Top Securities Holdings / Portfolio
Name Holding Value Quantity Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Oct 09 | SUNPHARMA12% ₹998 Cr 6,256,349 Divi's Laboratories Ltd (Healthcare)
Equity, Since 31 Mar 12 | DIVISLAB7% ₹613 Cr 1,000,031 Cipla Ltd (Healthcare)
Equity, Since 31 May 08 | CIPLA6% ₹509 Cr 3,200,000 Lupin Ltd (Healthcare)
Equity, Since 31 Aug 08 | LUPIN6% ₹509 Cr 2,683,991 Apollo Hospitals Enterprise Ltd (Healthcare)
Equity, Since 30 Sep 20 | APOLLOHOSP6% ₹494 Cr 648,795 Dr Reddy's Laboratories Ltd (Healthcare)
Equity, Since 30 Jun 11 | DRREDDY6% ₹493 Cr 3,916,074 Medplus Health Services Ltd (Healthcare)
Equity, Since 30 Nov 22 | 5434274% ₹305 Cr 3,627,277 Vijaya Diagnostic Centre Ltd (Healthcare)
Equity, Since 30 Sep 21 | 5433503% ₹291 Cr 2,886,684 GlaxoSmithKline Pharmaceuticals Ltd (Healthcare)
Equity, Since 31 Aug 22 | GLAXO3% ₹254 Cr 913,226 Gland Pharma Ltd (Healthcare)
Equity, Since 30 Nov 20 | GLAND3% ₹247 Cr 1,320,549 9. Invesco India Infrastructure Fund
Invesco India Infrastructure Fund
Growth Launch Date 21 Nov 07 NAV (30 Sep 25) ₹62.34 ↑ 0.06 (0.10 %) Net Assets (Cr) ₹1,524 on 31 Aug 25 Category Equity - Sectoral AMC Invesco Asset Management (India) Private Ltd Rating ☆☆☆ Risk High Expense Ratio 2.09 Sharpe Ratio -0.4 Information Ratio 0 Alpha Ratio 0 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 30 Sep 20 ₹10,000 30 Sep 21 ₹17,896 30 Sep 22 ₹18,800 30 Sep 23 ₹24,462 30 Sep 24 ₹40,508 Returns for Invesco India Infrastructure Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 30 Sep 25 Duration Returns 1 Month -0.3% 3 Month -5% 6 Month 9% 1 Year -9% 3 Year 25.1% 5 Year 29.8% 10 Year 15 Year Since launch 10.8% Historical performance (Yearly) on absolute basis
Year Returns 2024 33.2% 2023 51.1% 2022 2.3% 2021 55.4% 2020 16.2% 2019 6.1% 2018 -15.8% 2017 48.1% 2016 0.8% 2015 -2.6% Fund Manager information for Invesco India Infrastructure Fund
Name Since Tenure Amit Nigam 3 Sep 20 5 Yr. Sagar Gandhi 1 Mar 25 0.5 Yr. Data below for Invesco India Infrastructure Fund as on 31 Aug 25
Equity Sector Allocation
Sector Value Industrials 55.7% Basic Materials 9.88% Consumer Cyclical 8.42% Communication Services 6.21% Health Care 5.03% Utility 5.01% Real Estate 4.77% Technology 2.97% Energy 1.8% Asset Allocation
Asset Class Value Cash 0.21% Equity 99.79% Top Securities Holdings / Portfolio
Name Holding Value Quantity Bharti Airtel Ltd (Communication Services)
Equity, Since 31 Aug 21 | BHARTIARTL6% ₹95 Cr 501,000
↓ -20,351 Delhivery Ltd (Industrials)
Equity, Since 31 Aug 24 | 5435295% ₹80 Cr 1,698,708 InterGlobe Aviation Ltd (Industrials)
Equity, Since 31 May 25 | INDIGO5% ₹71 Cr 126,000
↑ 60,903 Apollo Hospitals Enterprise Ltd (Healthcare)
Equity, Since 30 Jun 24 | APOLLOHOSP5% ₹71 Cr 93,000
↑ 34,098 Supreme Industries Ltd (Industrials)
Equity, Since 30 Apr 24 | SUPREMEIND4% ₹59 Cr 132,105
↓ -14,727 Ramco Cements Ltd (Basic Materials)
Equity, Since 31 Jul 23 | RAMCOCEM4% ₹57 Cr 540,000
↑ 91,088 ZF Commercial Vehicle Control Systems India Ltd (Consumer Cyclical)
Equity, Since 30 Jun 23 | ZFCVINDIA3% ₹53 Cr 37,441
↑ 303 PTC Industries Ltd (Industrials)
Equity, Since 30 Sep 24 | 5390063% ₹50 Cr 35,841 Honeywell Automation India Ltd (Industrials)
Equity, Since 30 Sep 20 | HONAUT3% ₹46 Cr 11,850
↓ -142 Power Grid Corp Of India Ltd (Utilities)
Equity, Since 30 Apr 22 | POWERGRID3% ₹45 Cr 1,650,305 10. Kotak Infrastructure & Economic Reform Fund
Kotak Infrastructure & Economic Reform Fund
Growth Launch Date 25 Feb 08 NAV (30 Sep 25) ₹64.012 ↓ -0.14 (-0.22 %) Net Assets (Cr) ₹2,313 on 31 Aug 25 Category Equity - Sectoral AMC Kotak Mahindra Asset Management Co Ltd Rating ☆☆☆☆ Risk High Expense Ratio 2.01 Sharpe Ratio -0.52 Information Ratio -0.04 Alpha Ratio -1.88 Min Investment 5,000 Min SIP Investment 1,000 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 30 Sep 20 ₹10,000 30 Sep 21 ₹18,729 30 Sep 22 ₹20,862 30 Sep 23 ₹26,765 30 Sep 24 ₹42,027 Returns for Kotak Infrastructure & Economic Reform Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 30 Sep 25 Duration Returns 1 Month 0.7% 3 Month -4% 6 Month 10.9% 1 Year -11.4% 3 Year 21.3% 5 Year 30.1% 10 Year 15 Year Since launch 11.1% Historical performance (Yearly) on absolute basis
Year Returns 2024 32.4% 2023 37.3% 2022 15.6% 2021 57.3% 2020 3.4% 2019 3.6% 2018 -19.6% 2017 45.3% 2016 9.2% 2015 -0.2% Fund Manager information for Kotak Infrastructure & Economic Reform Fund
Name Since Tenure Nalin Bhatt 1 Oct 23 1.92 Yr. Data below for Kotak Infrastructure & Economic Reform Fund as on 31 Aug 25
Equity Sector Allocation
Sector Value Industrials 45.74% Basic Materials 14.79% Communication Services 10.57% Consumer Cyclical 10.4% Energy 8.15% Utility 4.71% Real Estate 1.97% Financial Services 1.64% Technology 1.33% Asset Allocation
Asset Class Value Cash 0.68% Equity 99.32% Top Securities Holdings / Portfolio
Name Holding Value Quantity Bharti Airtel Ltd (Communication Services)
Equity, Since 30 Apr 20 | BHARTIARTL7% ₹164 Cr 870,000
↓ -57,000 Reliance Industries Ltd (Energy)
Equity, Since 31 Mar 25 | RELIANCE5% ₹117 Cr 864,000
↓ -36,000 Shree Cement Ltd (Basic Materials)
Equity, Since 31 Dec 11 | SHREECEM4% ₹102 Cr 35,000 Larsen & Toubro Ltd (Industrials)
Equity, Since 28 Feb 15 | LT4% ₹99 Cr 274,000
↓ -36,000 Kalpataru Projects International Ltd (Industrials)
Equity, Since 31 Aug 17 | KPIL3% ₹80 Cr 639,927 UltraTech Cement Ltd (Basic Materials)
Equity, Since 31 Mar 15 | ULTRACEMCO3% ₹76 Cr 60,000 Solar Industries India Ltd (Basic Materials)
Equity, Since 31 Oct 15 | SOLARINDS3% ₹74 Cr 54,000 Bosch Ltd (Consumer Cyclical)
Equity, Since 30 Sep 24 | BOSCHLTD3% ₹70 Cr 17,500 VST Tillers Tractors Ltd (Industrials)
Equity, Since 30 Apr 24 | VSTTILLERS3% ₹69 Cr 130,659 Mahindra Logistics Ltd (Industrials)
Equity, Since 31 Jan 24 | MAHLOG3% ₹63 Cr 1,983,265
↑ 540,890
ഇവിടെ നൽകിയിരിക്കുന്ന വിവരങ്ങൾ കൃത്യമാണെന്ന് ഉറപ്പാക്കാൻ എല്ലാ ശ്രമങ്ങളും നടത്തി. എന്നിരുന്നാലും, ഡാറ്റയുടെ കൃത്യത സംബന്ധിച്ച് ഒരു ഉറപ്പുമില്ല. നിക്ഷേപം നടത്തുന്നതിന് മുമ്പ് ദയവായി സ്കീം വിവര പ്രമാണം ഉപയോഗിച്ച് പരിശോധിക്കുക.
You Might Also Like
AMFI Registration No. 112358 | CIN: U74999MH2016PTC282153
Shepard Technologies Pvt. Ltd. (with ARN code 112358) makes no warranties or representations, express or implied, on products offered through the platform. It accepts no liability for any damages or losses, however caused, in connection with the use of, or on the reliance of its product or related services. Terms and conditions of the website are applicable.
©2025 Shepard Technologies Private Limited. All Rights Reserved
Research Highlights for LIC MF Infrastructure Fund